Lily Koo, Ph.D.

FDA, Center for Biologics Evaluation and Research (CBER)

Dr. Lily Koo is currently serving as a biomedical engineer for the Advanced Technologies Program within the Office of Director at the FDA’s Center for Biologics Evaluation and Research (CBER). Prior to this role, she served as a reviewer/inspector in the Office of Compliance and Biologics Quality (OCBQ) in CBER, a lead reviewer of respiratory devices at the Center for Device and Radiological Health (CDRH), and a staff scientist at the National Institutes of Health (NIH). Dr. Koo received her B.S. in bioengineering from University of Pennsylvania and her Ph.D. in chemical engineering from Massachusetts Institute of Technology.